❭ Research by medical division ❭ Laboratory Medicine ❭ Microbiology ❭ J.A. Dahl's group ❭ Funding agencies ❭

Our research is funded by:

The Research Council of Norway

  • FRIPRO
  • BEDRE BEHANDLING

The Norwegian Cancer Society

The South-Eastern Norway Regional Health Authority

UiO:LifeScience
(http://www.uio.no/english/research/strategic-research-areas/life-science/)

Anders Jahres fond til vitenskapens fremme (MEDISIN)

 

 
Page visits: 1390
Scroll to top

Home Microbiology J.A. Dahl's group

  • Group members
  • Projects
  • Publications
  • Available positions
  • Funding agencies
  • Collaborations

Recent publications

Brunvoll SH, Nygaard AB, Fagerland MW, Holland P, Ellingjord-Dale M, Dahl JA, Søraas A (2022)
Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection
Int J Infect Dis, 126, 10-13
DOI 10.1016/j.ijid.2022.11.009, PubMed 36375693

Holland P, Wildhagen M, Istre M, Reiakvam OM, Dahl JA, Søraas A (2022)
Cri du chat syndrome patients have DNA methylation changes in genes linked to symptoms of the disease
Clin Epigenetics, 14 (1), 128
DOI 10.1186/s13148-022-01350-3, PubMed 36242045

Brunvoll SH, Nygaard AB, Ellingjord-Dale M, Holland P, Istre MS, Kalleberg KT, Søraas CL, Holven KB, Ulven SM, Hjartåker A, Haider T, Lund-Johansen F, Dahl JA, Meyer HE, Søraas A (2022)
Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial
BMJ, 378, e071245
DOI 10.1136/bmj-2022-071245, PubMed 36215222

More

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Email: trond.olav.berg@rr-research.no

Cookie policy

Accessibility statement (in Norwegian)